Clinical Trial: Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational

Official Title: Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa

Brief Summary: Recessive dystrophic epidermolysis bullosa (RDEB) is a disease caused by genetic mutations in the gene for type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening subjects with RDEB to evaluate characteristics of the subjects and their cells in order to develop new strategies of therapy and determine whether subjects could be candidates for treatment studies.

Detailed Summary:
Sponsor: Stanford University

Current Primary Outcome: Identification of subjects with Recessive Dystrophic Epidermolysis Bullosa [ Time Frame: 4 years ]

Identification of subjects with Recessive Dystrophic Epidermolysis Bullosa for future studies


Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Stanford University

Dates:
Date Received: November 20, 2009
Date Started: November 2009
Date Completion: September 2016
Last Updated: March 17, 2016
Last Verified: March 2016